TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
GLSI

Greenwich Lifesciences Inc

Healthcare · Biotechnology

17.50$ +0.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement GLSI
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
0.10 0.11 0.22 0.08 0.27 0.50 0.60 1.19 1.27
– 0.04 0.07 0.06 0.08 0.12 0.13 0.24 0.16
0.13 0.14 0.29 0.15 0.35 0.62 0.73 1.35 1.44
-0.13 -0.14 -0.29 -0.15 -0.36 -0.62 -0.73 -1.36 -1.44
– 0.00 0.00 0.00 0.00 0.02 – – –
-0.13 -0.14 -0.29 -0.15 -0.35 -0.61 -0.69 -1.34 -1.43
0.00 -0.01 0.00 0.00 0.00 -0.02 0.00 – –
-0.13 -0.14 -0.29 -0.15 -0.35 -0.61 -0.69 -1.34 -1.43
-0.13 -0.14 -0.29 -0.15 -0.35 -0.61 -0.69 -1.34 -1.43

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?